Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 250

2.

Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma.

Kubo S, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Yamamoto T, Ikebe T, Wakasa K, Nishiguchi S, Kinoshita H.

Cancer. 2000 Mar 1;88(5):1016-24.

PMID:
10699889
3.

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.

Hung IF, Poon RT, Lai CL, Fung J, Fan ST, Yuen MF.

Am J Gastroenterol. 2008 Jul;103(7):1663-73. doi: 10.1111/j.1572-0241.2008.01872.x. Epub 2008 Jul 4.

PMID:
18616655
4.

The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.

Chuma M, Hige S, Kamiyama T, Meguro T, Nagasaka A, Nakanishi K, Yamamoto Y, Nakanishi M, Kohara T, Sho T, Yamamoto K, Horimoto H, Kobayashi T, Yokoo H, Matsushita M, Todo S, Asaka M.

J Gastroenterol. 2009;44(9):991-9. doi: 10.1007/s00535-009-0093-z. Epub 2009 Jun 25.

PMID:
19554391
5.

High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.

Yang T, Lu JH, Zhai J, Lin C, Yang GS, Zhao RH, Shen F, Wu MC.

Eur J Surg Oncol. 2012 Aug;38(8):683-91. doi: 10.1016/j.ejso.2012.04.010. Epub 2012 May 22.

PMID:
22621971
6.

High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma.

Xia F, Lai EC, Lau WY, Ma K, Li X, Bie P, Qian C.

Ann Surg Oncol. 2012 Apr;19(4):1284-91. doi: 10.1245/s10434-011-2042-3. Epub 2011 Sep 13.

PMID:
21913016
7.

Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.

Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G.

Carcinogenesis. 2008 Sep;29(9):1685-91. doi: 10.1093/carcin/bgm301. Epub 2008 Jan 12.

PMID:
18192693
8.

Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.

Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.

J Gastroenterol Hepatol. 2011 Nov;26(11):1638-45. doi: 10.1111/j.1440-1746.2011.06777.x.

PMID:
22011297
9.

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma.

Ohkubo K, Kato Y, Ichikawa T, Kajiya Y, Takeda Y, Higashi S, Hamasaki K, Nakao K, Nakata K, Eguchi K.

Cancer. 2002 May 15;94(10):2663-8.

10.

High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection.

Qu LS, Jin F, Huang XW, Shen XZ.

J Gastrointest Surg. 2010 Jul;14(7):1111-20. doi: 10.1007/s11605-010-1211-1. Epub 2010 Apr 27.

PMID:
20422305
11.

Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.

Huang L, Li J, Lau WY, Yan J, Zhou F, Liu C, Zhang X, Shen J, Wu M, Yan Y.

J Gastroenterol Hepatol. 2012 Jan;27(1):158-64. doi: 10.1111/j.1440-1746.2011.06888.x.

PMID:
21871026
12.

Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.

Tsai FC, Liu CJ, Chen CL, Chen PJ, Lai MY, Kao JH, Chen DS.

J Viral Hepat. 2007 Mar;14(3):153-60.

PMID:
17305880
13.

Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion.

Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Hamamura K, Imai Y, Yoshida H, Shiina S, Omata M.

Hepatology. 2000 Dec;32(6):1216-23.

PMID:
11093727
14.

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ.

J Natl Cancer Inst. 2005 Feb 16;97(4):265-72.

PMID:
15713961
15.

Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.

Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, Fu SY, Wu MC.

Ann Surg. 2013 Mar;257(3):490-505. doi: 10.1097/SLA.0b013e318262b218.

PMID:
22868358
16.

Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.

Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.

J Gastroenterol Hepatol. 2009 Aug;24(8):1437-44. doi: 10.1111/j.1440-1746.2009.05863.x. Epub 2009 May 28.

PMID:
19486255
17.

Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.

Jang JW, Choi JY, Bae SH, Kim CW, Yoon SK, Cho SH, Yang JM, Ahn BM, Lee CD, Lee YS, Chung KW, Sun HS.

J Hepatol. 2004 Sep;41(3):427-35.

PMID:
15336446
18.

Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.

Mahmood S, Niiyama G, Kamei A, Izumi A, Nakata K, Ikeda H, Suehiro M, Kawanaka M, Togawa K, Yamada G.

Liver Int. 2005 Apr;25(2):220-5.

PMID:
15780042
19.

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.

Chan HL, Tse CH, Mo F, Koh J, Wong VW, Wong GL, Lam Chan S, Yeo W, Sung JJ, Mok TS.

J Clin Oncol. 2008 Jan 10;26(2):177-82. doi: 10.1200/JCO.2007.13.2043.

PMID:
18182659
20.

Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.

Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS.

J Infect Dis. 2006 May 1;193(9):1258-65. Epub 2006 Apr 4.

PMID:
16586363

Supplemental Content

Support Center